NCT02723201 TAK-020 Relative Bioavailability and Food Effect Study in Healthy Participants Status COMPLETED Phase PHASE1
NCT02716987 Study to Determine D-amino Acid Oxidase Brain Enzyme Occupancy of TAK-831 After Single-dose Oral Administration Status COMPLETED Phase PHASE1
NCT02716116 A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02713061 A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants Status WITHDRAWN Phase PHASE2
NCT02709746 Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE3
NCT02709655 Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE3
NCT02706834 Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants Status COMPLETED Phase PHASE1
NCT02706626 Trial of Brigatinib After Treatment With Next-Generation ALK Inhibitors Status TERMINATED Phase PHASE2
NCT02695719 Lubiprostone for Treatment of Chronic Idiopathic Constipation Status COMPLETED Phase PHASE3
NCT02685007 RollOut -Pre-Rolled TachoSil in Laparoscopic Utilisation. A Non-Interventional Study Status COMPLETED Phase N/A
NCT02679508 Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety Status COMPLETED Phase PHASE4
NCT02678676 An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications Status COMPLETED Phase N/A
NCT02669121 Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults Status COMPLETED Phase PHASE2
NCT02669082 The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy Status COMPLETED Phase PHASE4
NCT02661490 Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population Status COMPLETED Phase PHASE2
NCT02655237 A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids Status COMPLETED Phase PHASE3
NCT02655224 A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids Status COMPLETED Phase PHASE3